乳腺癌
Breast cancer.
作者信息
Sainsbury R
机构信息
Department of Surgery, Royal Infirmary, Huddersfield, UK.
出版信息
Postgrad Med J. 1996 Nov;72(853):663-6. doi: 10.1136/pgmj.72.853.663.
Abstract
The management of patients with breast cancer has been changing over the last few years and this article highlights some areas of particular interest. The changes have been brought about against a background of an increasing disease incidence coupled with increasing political aspirations from patients and their relatives. This paper focuses on organisational aspects of breast cancer care, screening, induction and high-dose chemotherapy, clinical trials, genetics, training of surgical and nonsurgical oncologists and future prospects.
摘要
在过去几年中，乳腺癌患者的管理方式一直在发生变化，本文重点介绍了一些特别值得关注的领域。这些变化是在疾病发病率不断上升以及患者及其亲属政治诉求不断增加的背景下产生的。本文重点关注乳腺癌护理的组织方面、筛查、诱导和大剂量化疗、临床试验、遗传学、外科和非外科肿瘤学家的培训以及未来前景。
相似文献
1
Breast cancer.乳腺癌
Postgrad Med J. 1996 Nov;72(853):663-6. doi: 10.1136/pgmj.72.853.663.
2
Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.对肿瘤大小为5厘米或更大的无淋巴结转移乳腺癌患者行乳房切除术治疗，无论是否接受辅助全身治疗且未接受放疗，其局部区域复发率较低：五项国家外科辅助乳腺和肠道项目随机临床试验的结果
J Clin Oncol. 2006 Aug 20;24(24):3927-32. doi: 10.1200/JCO.2006.06.9054.
3
A peek into epidemiology, screening, management of breast cancer in developing countries: Experience from two regional cancer centers in India.深入了解发展中国家乳腺癌的流行病学、筛查与管理：来自印度两个地区癌症中心的经验。
Breast J. 2018 May;24(3):422-423. doi: 10.1111/tbj.12965. Epub 2017 Dec 5.
4
Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancer.绝经后淋巴结阳性乳腺癌患者乳房切除术后观察与环磷酰胺、氟尿嘧啶、泼尼松联合或不联合他莫昔芬辅助治疗的随机试验
J Clin Oncol. 1988 Sep;6(9):1388-96. doi: 10.1200/JCO.1988.6.9.1388.
5
Randomized clinical trials in breast cancer: a tabular summary. Part 1: Primary breast cancer.乳腺癌随机临床试验：表格总结。第1部分：原发性乳腺癌。
Arch Geschwulstforsch. 1986;56(3):211-36.
6
Occasional notes. The management of early breast cancer.
N Engl J Med. 1982 Jun 10;306(23):1430-2. doi: 10.1056/NEJM198206103062321.
7
Induction chemotherapy of breast cancer.乳腺癌的诱导化疗。
Prog Clin Biol Res. 1985;201:105-16.
8
The Association of Cancer Physicians Breast Cancer Forum: implications of Calman-Hine for breast cancer services.癌症医师协会乳腺癌论坛：卡尔曼-海恩报告对乳腺癌服务的影响
Br J Cancer. 2000 Jul;83(1):135-40. doi: 10.1054/bjoc.2000.1235.
9
Postmastectomy radiation therapy in locally advanced breast cancer.局部晚期乳腺癌的乳房切除术后放射治疗
Exp Oncol. 2013 Dec;35(4):258-66.
10
[Inflammatory cancer of the breast. Assessment after 6 years of 16 patients treated by primary immunochemotherapy].[炎性乳腺癌。16例接受原发性免疫化疗患者6年后的评估]
J Gynecol Obstet Biol Reprod (Paris). 1985;14(4):515-21.
本文引用的文献
1
Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma.
N Engl J Med. 1994 May 5;330(18):1253-9. doi: 10.1056/NEJM199405053301801.
2
Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.携带BRCA1基因突变者患癌风险。乳腺癌连锁协会。
Lancet. 1994 Mar 19;343(8899):692-5. doi: 10.1016/s0140-6736(94)91578-4.
3
Intra-arterial chemotherapy in patients with breast cancer: a feasibility study.乳腺癌患者的动脉内化疗：一项可行性研究。
Br J Cancer. 1995 Mar;71(3):605-9. doi: 10.1038/bjc.1995.117.
4
Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region.三年的乳房筛查间隔时间是否过长？英国国家医疗服务体系（NHS）乳房筛查项目西北地区的间期癌发生情况。
BMJ. 1995 Jan 28;310(6974):224-6. doi: 10.1136/bmj.310.6974.224.
5
High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer.大型早期乳腺癌采用原发性新辅助灌注化疗的完全缓解率高。
J Clin Oncol. 1995 Feb;13(2):424-9. doi: 10.1200/JCO.1995.13.2.424.
6
Does it matter where you live? Treatment variation for breast cancer in Yorkshire. The Yorkshire Breast Cancer Group.你居住的地方有关系吗？约克郡乳腺癌的治疗差异。约克郡乳腺癌小组。
Br J Cancer. 1995 Jun;71(6):1275-8. doi: 10.1038/bjc.1995.246.
7
Influence of clinician workload and patterns of treatment on survival from breast cancer.临床医生工作量及治疗模式对乳腺癌患者生存率的影响。
Lancet. 1995 May 20;345(8960):1265-70. doi: 10.1016/s0140-6736(95)90924-9.
8
Screening mammography and public health policy: the need for perspective.
Lancet. 1995 Jul 1;346(8966):29-32. doi: 10.1016/s0140-6736(95)92655-0.
9
UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening.英国癌症协作中心（UKCCCR）关于乳腺癌筛查中采用单视图和双视图乳房X线摄影的多中心随机对照试验。
BMJ. 1995 Nov 4;311(7014):1189-93. doi: 10.1136/bmj.311.7014.1189.
10
The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer.在晚期乳腺癌和卵巢癌患者中使用粒细胞集落刺激因子以增加阿霉素的治疗强度。
Br J Cancer. 1989 Jul;60(1):121-5. doi: 10.1038/bjc.1989.234.
Zotero 插件